Search For "drug control"
Russian Sputnik V COVID-19 vaccine to be tested on 100 Indian volunteers
Updated : 5 years, 4 months ago IST
Moscow [Russia], October 23 (ANI): The Russian Sputnik V vaccine against COVID-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Sputnik on Thursday.
Read More
Rajasthan: Drug control officers appointed to ensure oxygen for COVID-19 p
Updated : 5 years, 5 months ago IST
Jaipur (Rajasthan) [India], September 25 (ANI): Rajasthan Health Minister Raghu Sharma on Thursday appointed drug control officers at oxygen production firms and companies to keep a watch on oxygen manufacturing in Jaipur to ensure an adequate supply of oxygen to coronavirus patients.
Read More
DCGI approves India's first CRISPR Covid-19 test developed by the Tata Gro
Updated : 5 years, 5 months ago IST
New Delhi [India], September 19 (ANI): The Drug Controller General of India (DCGI), on Saturday gave approval for the commercial launch of India's first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) test, developed by the Tata Group and CSIR-IGIB (Institute of Genomics a
Read More
Dr Reddy's launches Redyx (Remdesivir) in India for COVID-19 treatment
Updated : 5 years, 6 months ago IST
Hyderabad (Telangana) [India], September 9 (ANI): Dr Reddy's Laboratories on Wednesday announced the launch of Remdesivir under the brand name Redyx for Indian markets.
Read More
Lupin launches Favipiravir in India for COVID treatment at Rs 49 per table
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 5 (ANI): Pharma major Lupin Ltd on Wednesday announced the launch of Favipiravir in India under the brand name Covihalt for treatment of mild to moderate COVID-19.
Read More
2 international drug rackets busted in Gurugram
Updated : 5 years, 7 months ago IST
Gurugram (Haryana) [India], July 28 (ANI): Local police and the Gurugram Drug Control department on Tuesday, busted two big international drug rackets and seized drugs including narcotics and COVID-19 drugs worth lakhs.
Read More
Cipla gets regulatory nod for launch of Ciplenza to treat mild to moderate
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Pharmaceutical major Cipla said on Friday it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.
Read More
COVID-19: DCGI nod to Jubilant Generics to manufacture, sell remdesivir f
Updated : 5 years, 7 months ago IST
New Delhi [India], July 20 (ANI): The Drug Controller General of India (DCGI) has granted permission to pharma giant- Jubilant Generics Ltd to manufacture and market the anti-viral drug remdesivir for "restricted emergency use" on hospitalised COVID-19 patients, a senior health ministry offi
Read More
Zydus gets Mexican regulator nod to conduct clinical trials with Pegylated
Updated : 5 years, 8 months ago IST
Ahmedabad (Gujarat) [India], July 17 (ANI): Pharmaceutical major Zydus said on Friday it has got approval from Mexico's Federal Commission for the Protection against Sanitary Risk (COFEPRIS) to conduct clinical trials with its biological therapy 'Pegylated Interferon alpha-2b' for the treatm
Read More
DCGI gives market approval for Pneumococcal Polysaccharide Conjugate Vacci
Updated : 5 years, 8 months ago IST
New Delhi [India], July 15 (ANI): The Drug Controller General of India (DCGI) has given approval to the first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine.
Read More
DCGI approves Itolizumab injection for restricted emergency use on COVID-1
Updated : 5 years, 8 months ago IST
New Delhi [India], July 11 (ANI): The Drug Controller General of India (DCGI) granted its permission to Itolizumab injection for the restricted emergency use on COVID-19 patients with moderate to severe Acute Respiratory Distress Syndrome (ARDS) due to virus.
Read More
COVID19: Top drug regulator directs states drug controller to be vigilant
Updated : 5 years, 8 months ago IST
New Delhi [India], July 7 (ANI): The country's top drug regulator has directed all drug controller in the States and Union Territories to keep strict vigil to prevent the black marketing and sale of the anti-drug Remdesivir injection above the minimum retail price (MRP).
Read More